Head-to-Head

Novavax Inc vs. Vaxcyte, Inc. Common Stock

NVAX

Novavax Inc

$12.75 +15.80%

VS PCVX

Vaxcyte, Inc. Common Stock

$71.38 +9.79%

Vaxcyte, Inc. Common Stock (PCVX) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

NVAXPCVX
Market Cap $2.10 billion $11.15 billion

PCVX leads on 1 of 1 size & scale factors.

Dividend

NVAXPCVX
Dividend Yield 10.00% —

NVAX and PCVX split the dividend factors evenly.

Risk & Sentiment

NVAXPCVX
Short Interest 25.98% 0.13%

PCVX leads on 1 of 1 risk & sentiment factors.

Dig deeper: NVAX overview, NVAX financials, PCVX overview, PCVX financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.